News
Recognition at first glance
July 1, 2010 1:37 pm | by EurekAlert | Comments(Max-Planck-Gesellschaft) Max Planck researchers investigate facial recognition.
CryoSat-2 exceeding expectations
July 1, 2010 1:37 pm | by EurekAlert | Comments(European Space Agency) Today, participants at the Living Planet Symposium have been hearing about ESA's most recently launched mission, CryoSat-2. In orbit for almost three months, the satellite is in excellent health with scientists very encouraged by the first ice-thickness data...
Parkinson's Disease Foundation announces research awards totaling $1.2 million
July 1, 2010 1:37 pm | by EurekAlert | Comments(Parkinson's Disease Foundation) The Parkinson's Disease Foundation is pleased to announce awards totaling $1.2 million for research projects designed to understand the cause(s) of and find a cure for Parkinson's disease.
Genes for Extreme Longevity
July 1, 2010 1:36 pm | by Massachusetts Institute of Technology | CommentsScientists can predict who will live past 100 using a subset of 150 genetic variations.
Health Hazard Evaluations (HHEs) and Health Risk Assessments (HRAs)
July 1, 2010 1:31 pm | by U.S. Food & Drug Administration | CommentsFDA learns of problems with medical devices in different ways. Most often, a firm will notify its customers and FDA that it is issuing a recall. At other times, FDA's analysis of medical device reports will indicate a greater than expected failure rate...
Health insurance stocks drop deeper than market
July 1, 2010 12:45 pm | by TOM MURPHY - AP Business Writer - Associated Press | CommentsShares of Cigna Corp. and other major health insurers slid deeper than the broader market Thursday, as investors remain nervous about health care reform's impact on the sector.Managed care stocks have gone through spurts of volatility for more than a year now, as Congress debated and then...
Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease
July 1, 2010 11:33 am | by Bio-Medicine.Org | CommentsRICHMOND, Calif. , July 1 /- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that it has been awarded a second round of funding by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support studies in non-human primates for the development of a ZFP...
Aeras Global TB Vaccine Foundation Announces Appointment of Accomplished Pharmaceutical Executive as President and CEO
July 1, 2010 11:33 am | by Bio-Medicine.Org | CommentsJames E. Connolly Committed to Accelerating the Development of New Vaccines to Prevent Tuberculosis ROCKVILLE, Md. , July 1 /PRNewswire-USNewswire/ -- The Aeras Global TB Vaccine Foundation today announced that James E. Connolly has been named President and Chief Executive Officer....
Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
July 1, 2010 11:33 am | by Bio-Medicine.Org | CommentsBEIJING , July 1 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China , said today that Rita Zheng Liu , Chief Financial Officer, and Sam...
PartsSource Wins 2010 Venture of the Year Award
July 1, 2010 11:33 am | by Bio-Medicine.Org | CommentsAURORA, Ohio , July 1 /- PartsSource, the world's #1 eBusiness Solution provider for replacement medical repair parts for hospital equipment, has been honored with the 2010 Venture of the Year Award for Northern Ohio . The Ohio Venture Association is a group of northeast Ohio...
China PharmaHub Corp. Enters Into Definitive Agreement for Humanized Antibody
July 1, 2010 11:32 am | by Bio-Medicine.Org | CommentsBOSTON , July 1 /- China PharmaHub Corp. ("PharmaHub"), announced today that it has entered into a definitive agreement with Dr. David Weaver and Dr. Michael Rynkiewicz . In addition, PharmaHub contemplates merging with World Wide Relics, Inc. (OTC Bulletin Board: WRLC) of which it...
Targegen Acquisition Could Be Worth as Much as $560M
July 1, 2010 11:32 am | by San Diego Business Journal | CommentsTargegen Inc., a San Diego biotech developing a drug to treat blood diseases, agreed to be acquired by Sanofi-Aventis, a French public company for what could be $560 million if the company reaches certain milestones.
Chromosomal abnormality found for inherited clubfoot
July 1, 2010 9:36 am | by EurekAlert | Comments(Washington University School of Medicine) Although clubfoot is one of the most common congenital birth defects, few genetic causes have been found. Now, researchers at Washington University School of Medicine in St. Louis have found what they believe to be the most common cause of...
Needles improve exercise tolerance in heart patients
July 1, 2010 9:35 am | by EurekAlert | Comments(University Hospital Heidelberg) Acupuncture can improve exercise tolerance in patients suffering from chronic heart failure. This was determined in a clinical pilot study by the team headed by Dr. Johannes Backs, physician and study director at the Department of Internal Medicine...
Spanish public-sector workers complain most about their work environment
July 1, 2010 9:35 am | by EurekAlert | Comments(FECYT - Spanish Foundation for Science and Technology) Spanish employees from public institutions and companies report higher levels of psychological violence in their place of work than their Finnish counterparts. These are the results of a study headed by the University of...
